Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

Angelo, answer these questions for yourself.


The truth lies within:


1. What is the difference between patent protection and marketing exclusivity?

2. What is the Orange Book?

3. What is Rexista’s 505b2 NDA RLD?

4. Does the RLD have marketing exclusivity? If so, when does it expire?

5. Why does Rexista NOT get a Priority Review when all other ADF NDAs have?

6. What is the earliest date that Rexista could receive Full Approval from FDA?




(Hint: The Answer to #4, #5, and #6 is the same.)